Get Started

OTLC

PINK Oncotelic Therapeutics Inc
Oct 23, 2026 · 4:49 PM ET LAST TRADE Market Closed

$0.0169 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0169, and at the day’s high of $0.0213

YTD change
-78.44%
vs 20-day SMA
-19.23%
vs 200-day SMA
-60.29%

Price ranges

Previous day
$0.0161 $0.0190
open $0.0161 close $0.0190
+$0.0029 (+17.89%)
Today
$0.0164 $0.0213
open $0.0180 now $0.0169
-$0.0011 (-6.11%)
Past week
$0.0150 $0.0196
from $0.0180 now $0.0169
-$0.0011 (-6.11%)
Past month
$0.0150 $0.0280
from $0.0254 now $0.0169
-$0.0085 (-33.52%)
This year
$0.0150 $0.0940
from $0.0784 now $0.0169
-$0.0615 (-78.44%)

Price & Performance

-0.02 (-48.09%) / 6M

$0.0131$0.0302$0.0472$0.0643Apr 23Jul 24Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 95.3% away from all-time highs of $0.3600
  • OTLC is down 78% since the beginning of the year
  • OTLC is down 81% over the past 12 months
  • OTLC is down 34% over the past 1 month
  • 0% of all OTLC investors are betting against OTLC

OTLC reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -79.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.0008
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio 0.03
Enterprise value $21.8M
Beta -0.42

Balance sheet & scale

Income$247.5K
Revenue$250.0K
Cash$206.0K
Debt$14.2K
Income / Debt 17.39×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $7.7M

Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. The company was founded in 1988 and is headquartered in Agoura Hills, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $447.28 +2.04%
MRNA Moderna, Inc. $202.63 -17.57%
RVMD Revolution Medicines, Inc. $187.69 -3.39%
ROIV Roivant Sciences Ltd. $37.45 +1.77%
BNTX BioNTech SE Sponsored ADR $89.67 -1.77%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.